Literature DB >> 27001186

A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320.

William Townsend1, Rod J Johnson2, Bryson T Pottinger3, Nicholas Counsell1, Paul Smith1, Humra Chadwick1, Katy Evans4, Caroline Wickham4, Claudius E Rudin4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27001186     DOI: 10.3109/10428194.2015.1133814

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  1 in total

1.  Development of a Novel Clinical Prognostic Model for Patients With Angioimmunoblastic T-Cell Lymphoma.

Authors:  Chen Huang; Huichao Zhang; Yuhuan Gao; Lanping Diao; Lihong Liu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.